Prof. Dr. Giray BOZKAYA

1. Serum Kallistatin as a Biomarker of Sepsis and Mortality in Geriatric Patients with Acute Kidney Injury Kalistatin u serumu kao biomarker za sepsu i smrtnost kod gerijatrijskih bolesnika s akutnim oštećenjem bubrega

GİRENİZ TATAR B., Bozaci I., Serel A., Aktar M., Guvercin G., Vatansever B., et al.

Acta Clinica Croatica , cilt.65, sa.1, ss.12-21, 2026 (SCI-Expanded, Scopus)

2. Epiregulin levels and their association with prognostic factors in Hodgkin lymphoma: a case-control study

Yildirim Akan Ö., DEMİR İ., Bilgir F., BOZKAYA G., Ceylan Ş., BİLGİR O.

Annals of Hematology , cilt.105, sa.3, 2026 (SCI-Expanded, Scopus)

3. Investigation of the Effects of Quercetin on Early Brain Injury and Vasospasm in an Experimental Model of Subarachnoid Hemorrhage

Kayikci E., YILMAZ H., Benek H. B., Akcay E., TABANLI A., Bologur O., et al.

Turkish Neurosurgery , cilt.35, sa.6, ss.891-898, 2025 (SCI-Expanded, Scopus, TRDizin)

4. Prostasin: A Proteolytic Enzyme Increased in Women with Polycystic Ovary Syndrome

DEMİR İ., CEYLAN Y., Akan O. Y., Horoz E., BOZKAYA G., Yilmaz I.

Bratislava Medical Journal , cilt.126, sa.6, ss.1050-1057, 2025 (SCI-Expanded, Scopus)

5. Oxidative stress markers in breast cancer Meme kanserinde oksidatif stres belirteçleri

Fenercioğlu Ö., BOZKAYA G., Uzuncan N., Zengel B.

Pamukkale Medical Journal , cilt.17, sa.3, ss.402-411, 2024 (Scopus, TRDizin)

6. The relationship between stathmin-2 level and metabolic parameters in newly diagnosed type 2 diabetes mellitus patients

DEMİR İ., Yilmaz I., Horoz E., BOZKAYA G., BİLGİR O.

American Journal of the Medical Sciences , cilt.368, sa.1, ss.25-32, 2024 (SCI-Expanded, Scopus)

7. Epiregulin: A new prognostic molecule in non-Hodgkin lymphoma

DEMİR İ., Akan O. Y., Bilgir F., Yilmaz I., BOZKAYA G., BİLGİR O.

Irish Journal of Medical Science , cilt.193, sa.3, ss.1201-1207, 2024 (SCI-Expanded, Scopus)

8. Assessment of osteoprotegerin and RANKL levels and several cardiovascular risk scoring systems in acromegaly

Kocabas G. U., Yurekli B. S., Simsir I. Y., Ozgur S., Aksit M., BOZKAYA G.

Hormones , cilt.23, sa.1, ss.81-88, 2024 (SCI-Expanded, Scopus)

9. Relationship of Serum Kallistatin Level With Arterial Stiffness and Metabolic Parameters in Obesity-Related Chronic Kidney Disease

Mahser A., Serel A., BOZKAYA G., GİRENİZ TATAR B., Tatar E.

Experimental and Clinical Transplantation , cilt.22, sa.1, ss.243-246, 2024 (SCI-Expanded, Scopus)

10. The level of the neudesin in type-2 diabetic patients and the relationship between the metabolic parameters and carotid intima-media thickness

Karatas O., Calan M., Yuksel A., Chousein R., BOZKAYA G., Karatas M., et al.

Minerva Endocrinology , cilt.48, sa.3, ss.288-294, 2023 (SCI-Expanded, Scopus)

11. The method comparison and the verification of precision of Mindray CL-6000i thyroid function tests (TFTs)

BOZKAYA G., ŞİŞMAN A.

Turkish Journal of Biochemistry , cilt.46, sa.3, ss.255-262, 2021 (SCI-Expanded, Scopus, TRDizin)

12. Impact of chemerin, lipid profile, and insulin resistance on disease parameters in patients with multiple sclerosis

KÖŞKDERELİOĞLU A., Gedizlioglu M., Eskut N., Tamer P., Yalcin G., BOZKAYA G.

Neurological Sciences , cilt.42, sa.6, ss.2471-2479, 2021 (SCI-Expanded, Scopus)

13. Relationship between JAK2-V617F mutation and hematologic parameters in Philadelphia-negative chronic myeloproliferative neoplasms

Aksit M., BOZKAYA G., Uzuncan N., Bilgili S., ÖZLÜ C., Aksit M. Z.

Turkish Journal of Biochemistry , cilt.45, sa.6, ss.899-905, 2020 (SCI-Expanded, Scopus, TRDizin)

14. Correlation of serum C1q-tumour necrosis factor-related protein 5 levels with metabolic parameters and carotid intima-media thickness in newly diagnosed type 2 diabetes mellitus patients

Uçar I. M. B., Çalan M., Tatar E., Chousein R., Fenercioğlu Ö. E., BOZKAYA G., et al.

Hormones , cilt.19, sa.4, ss.559-564, 2020 (SCI-Expanded, Scopus)

15. Neudesin: a neuropeptide hormone decreased in subjects with polycystic ovary syndrome

BOZKAYA G., Fenercioglu O., DEMİR İ., Guler A., Aslanipour B., Calan M.

Gynecological Endocrinology , cilt.36, sa.10, ss.849-853, 2020 (SCI-Expanded, Scopus)

16. Relation of Decreased Circulating Sortilin Levels With Unfavorable Metabolic Profiles in Subjects With Newly Diagnosed Type 2 Diabetes Mellitus

DEMİR İ., Yildirim Akan O., Guler A., BOZKAYA G., Aslanipour B., Calan M.

American Journal of the Medical Sciences , cilt.359, sa.1, ss.8-16, 2020 (SCI-Expanded, Scopus)

17. The effects of epigenetic regulation on phenotypic expressivity in Turkish patients with familial Mediterranean fever

Doǧan E., GÜRSOY S., BOZKAYA G., ARSLANSOYU ÇAMLAR S., Kiliçarslan Ö. A., SOYLU A., et al.

Indian Journal of Rheumatology , cilt.14, sa.4, ss.297-303, 2019 (Scopus)

18. Evaluation of maternal serum ischemia modified albumin and total antioxidant status in ectopic pregnancy

BOZKAYA G., Karaca I., Fenercioglu O., Yildirim Karaca S., Bilgili S., Uzuncan N.

Journal of Maternal-Fetal and Neonatal Medicine , cilt.32, sa.12, ss.2003-2008, 2019 (SCI-Expanded, Scopus)

19. Association of decreased c1q/tumor necrosis factor-related protein-5 levels with metabolic and hormonal disturbance in polycystic ovary syndrome

Çalan M., Alan M., Alarslan P., Kocabaş G. Ü., BOZKAYA G., Acara A. Ç., et al.

Journal of the Turkish German Gynecology Association , cilt.20, sa.2, ss.89-96, 2019 (Scopus, TRDizin)

20. Circulating insulin-like peptide 5 levels and its association with metabolic and hormonal parameters in women with polycystic ovary syndrome

Bicer M., Alan M., Alarslan P., GÜLER A., Kocabas G., Imamoglu C., et al.

Journal of Endocrinological Investigation , cilt.42, sa.3, ss.303-312, 2019 (SCI-Expanded, Scopus)

21. Association of kallistatin with carotid intima-media thickness in women with polycystic ovary syndrome

Calan M., Guler A., Unal Kocabas G., Alarslan P., Bicer M., Imamoglu C., et al.

Minerva Endocrinologica , cilt.43, sa.3, ss.236-245, 2018 (SCI-Expanded, Scopus)

22. Matrix metalloproteinase-9, 10, and stress hyperglycaemia in acute kidney injury

Guvercin G., KARAKUŞ V., Aksit M., Dere Y., Aktar M., Alpay H., et al.

European Journal of Clinical Investigation , cilt.48, sa.7, 2018 (SCI-Expanded, Scopus)

23. Relationship between insulin resistance, hs-CRP, and body fat and serum osteoprotegerin/RANKL in prediabetic patients

BİLGİR O., Yavuz M., Bilgir F., AKAN O., Bayindir A. G., Calan M., et al.

Minerva Endocrinologica , cilt.43, sa.1, ss.19-26, 2018 (SCI-Expanded, Scopus)

24. Relationship Between Serum Macrophage Migration Inhibitory Factor Level and Insulin Resistance, High-Sensitivity C-Reactive Protein and Visceral Fat Mass in Prediabetes

BİLGİR O., Gökçen B., Bilgir F., Guler A., Calan M., Yuksel A., et al.

American Journal of the Medical Sciences , cilt.355, sa.1, ss.37-43, 2018 (SCI-Expanded, Scopus)

25. Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome

Bicer M., Guler A., Unal Kocabas G., Imamoglu C., Baloglu A., BİLGİR O., et al.

Endocrine Research , cilt.42, sa.2, ss.145-153, 2017 (SCI-Expanded, Scopus)

26. Increased adipsin is associated with carotid intima media thickness and metabolic disturbances in polycystic ovary syndrome

GÜRSOY DORUK Ö., Calan M., Yesil Senses P., Unal Kocabas G., Ozden E., Sari K. R., et al.

Clinical Endocrinology , cilt.85, sa.6, ss.910-917, 2016 (SCI-Expanded, Scopus)

27. Increased circulating macrophage migration inhibitory factor levels are associated with coronary artery disease

Kse A. Y., Bilgir F., BİLGİR O., Calan M., BOZKAYA G.

Clinics , cilt.70, sa.3, ss.169-172, 2015 (SCI-Expanded, Scopus)

28. Prognostic significance of serum galectin-3 levels in patients with hepatocellular cancer and chronic viral hepatitis

Ulu M., Alacacioglu A., Yuksel E., Pamukk B. O., BOZKAYA G., ARI A., et al.

Saudi Journal of Gastroenterology , cilt.21, sa.1, ss.47-50, 2015 (SCI-Expanded, Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Tez Danışmanlığı

Açık Erişim